Notice Type
Notice Title

Renewal of Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:


Active Ingredient:
Dosage Form:
New Zealand Sponsor:

Fibrinogen 900mg – 1300mg
Powder for injection
CSL Behring (NZ) Limited
CSL Behring GmbH, Marburg, Germany

Note: This renewed consent is valid for two years from 12 May 2015.

Dated this 20th day of March 2015.

SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).